Strados Labs is revolutionizing lung health monitoring with its innovative RESP® Biosensor, the first FDA-cleared wearable stethoscope designed to detect coughs and wheezes. This cutting-edge device allows for continuous, real-time monitoring of lung sounds and symptoms, offering a significant leap from traditional in-person assessments. Patients simply attach the device to their chest, where it captures vital data day and night, which is then transmitted to a mobile app and securely stored in the cloud for tracking and analysis.

Founded with the mission to "Make Every Breath Count," Strados Labs aims to enhance patient care across various respiratory conditions including asthma, chronic cough, COPD, and idiopathic pulmonary fibrosis. With over 600,000 validated coughs recorded and extensive use across four continents in multiple languages, Strados Labs not only provides critical insights for individual health management but also supports clinical trials by offering objective data on treatment responses. The company is making strides in ensuring that lung health can be monitored effortlessly from home or hospital settings!